Roche sänker budet på Genentech

I juli ifjol var budet 89 dollar per aktie. Då sa Genentechs styrelse nej tack. Nu meddelar läkemedelsjätten att man sänker budet och vänder sig direkt till småägarna.

Hårt tryck på Läkemedelsverket

Alltför många vill ansöka om Sverige som referensland i den decentraliserade processen för att godkänna läkemedel. Idag införs nya rutiner för att hantera situationen.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

New study of toxins and heart disease

Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study will try to evaluate this, and one thousand people are to be included.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Vattenfall is firing with biomass

Vattenfall will provide Denmark with electricity by means of biomass.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Swedish multi competent machine soon launched

The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.

Finnish Innovation Fund gets new leader

The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.

LEO Pharma - International Clinical Trial Manager

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Biogaia's advance goes on

In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.

Norwegian describes scrapie gene

Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

New faces in Pronova Biopharma team

The Norwegian company Pronova Biopharma has recently changed the management team structure.

Control of blood vessels can treat obesity

Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.

Mathematician new dean at DTU

On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.

Glucose facilitates the use of indigo

The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Ambassador program makes MVA big in Japan

The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a significant difference for their sister clusters.